Nassiba Taib

Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer

Abdul Quaiyoom Khan, S. Uddin, A. Raza, 2022, Journal of experimental & clinical cancer research : CR.

Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines

H. Yassine, S. Uddin, Mona O. Mohsen, 2022, Annals of medicine.

The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update.

V. Inchakalody, Nassiba Taib, M. Merhi, 2023, Seminars in cancer biology.

The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.

S. Uddin, A. Raza, V. Inchakalody, 2021, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR).

A. Raza, V. Inchakalody, S. Mestiri, 2023, European journal of pharmacology.

SARS-CoV-2 S Protein Binding hACE2: Viral Entry, Pathogenesis, Prognosis, and Potential Therapeutic Targets

S. Uddin, A. Raza, V. Inchakalody, 2020 .

Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid ex-vivo T cells expansion protocol for adoptive immunotherapy: A pilot study

L. Abu-Raddad, H. Yassine, N. Allahverdi, 2023, Frontiers in Immunology.

Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy

C. Maccalli, F. Azizi, A. Raza, 2023, Journal of Translational Medicine.

Chronic inflammation and cancer; the two sides of a coin.

V. Inchakalody, S. Mestiri, Takwa Bedhiafi, 2023, Life sciences.